We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$335M
AUM Growth
+$66.9M
Cap. Flow
-$37.3M
Cap. Flow %
-11.13%
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134

Top Buys

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$16M
2
STM icon
STMicroelectronics
STM
+$13.6M
3
APH icon
Amphenol
APH
+$10.9M
4
STX icon
Seagate
STX
+$7.07M
5
F icon
Ford
F
+$6.02M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$18.4M
2
LITE icon
Lumentum
LITE
+$14.5M
3
AXTI icon
AXT Inc
AXTI
+$13.3M
4
TSEM icon
Tower Semiconductor
TSEM
+$11.9M
5
MU icon
Micron Technology
MU
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 38.35%
2 Healthcare 29.66%
3 Financials 6.33%
4 Miscellaneous 6.14%
5 Consumer Discretionary 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OUT icon
226
Outfront Media
OUT
$5.1B
$182K 0.05%
+5,553
New +$172K
MSGE icon
227
Madison Square Garden
MSGE
$3.66B
$177K 0.05%
+2,186
New +$149K
EAT icon
228
Brinker International
EAT
$9.62B
$175K 0.05%
+1,044
New +$154K
NTLA icon
229
CALL
Intellia Therapeutics
NTLA
$1.79B
$172K 0.05%
512
-28
-5% -$392
EDU icon
230
New Oriental
EDU
$9.47B
$172K 0.05%
3,737
-219
-6% -$11.1K
HLT icon
231
Hilton Worldwide
HLT
$70B
$172K 0.05%
+519
New +$171K
PEPG icon
232
PepGen
PEPG
$215M
$171K 0.05%
95,003
+56,851
+149% +$92.4K
CBRS
233
Cerebras Systems
CBRS
$49.9B
$171K 0.05%
+773
New +$182K
MNSO icon
234
MINISO
MNSO
$2.86B
$170K 0.05%
14,123
-20,400
-59% -$287K
PTHS
235
Pelthos Therapeutics
PTHS
$93.2M
$170K 0.05%
6,007
TKO icon
236
TKO Group
TKO
$13.6B
$169K 0.05%
+841
New +$164K
HROW icon
237
Harrow
HROW
$1.44B
$169K 0.05%
+3,986
New +$148K
BIIB icon
238
CALL
Biogen
BIIB
$32.6B
$169K 0.05%
+154
New +$29.5K
CMPS
239
Compass Pathways
CMPS
$1.84B
$168K 0.05%
11,845
+3,785
+47% +$38.4K
BNTC icon
240
Benitec Biopharma
BNTC
$436M
$167K 0.05%
12,493
-5,814
-32% -$69K
SLN
241
Silence Therapeutics
SLN
$907M
$167K 0.05%
+15,170
New +$107K
TTWO icon
242
Take-Two Interactive
TTWO
$40.1B
$164K 0.05%
+655
New +$145K
LBRX
243
LB Pharmaceuticals
LBRX
$1.59B
$160K 0.05%
+4,926
New +$145K
ABEO icon
244
Abeona Therapeutics
ABEO
$343M
$159K 0.05%
+25,745
New +$141K
INCY icon
245
PUT
Incyte
INCY
$25.7B
$159K 0.05%
266
TRAX
246
First Tracks Biotherapeutics
TRAX
$1.45B
$159K 0.05%
+7,903
New +$148K
AMZN icon
247
Amazon
AMZN
$2.79T
$158K 0.05%
+665
New +$167K
DCH
248
Dauch Corp
DCH
$1.66B
$155K 0.05%
+28,651
New +$174K
AEVA
249
Aeva Technologies
AEVA
$1.09B
$153K 0.05%
+5,325
New +$105K
KTTA icon
250
Pasithea Therapeutics
KTTA
$19.4M
$150K 0.04%
290,555

Similar funds

Persistent Asset Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.

  • Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
  • Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
  • Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
  • Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
  • Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
  • Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
  • Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.